Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

CDT Equity Inc

CDT ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$2.92

▼ -6.11%

Market Cap $2.30M · Vol 3.70K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.30M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

51.23

Momentum

Beta

1.53

vs Market

52W High

$3,440.00

99.92% below

52W Low

$2.53

15.42% above

Volume

3.70K

Avg 7.89K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

77.06%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, CDT Equity Inc (CDT) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CDT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.62%

-16.57%

-84.30%

-98.92%

YTD

-99.09%

-99.91%

-100.00%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-39,224,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-796.99% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	786.67K

Technical Indicators

50-Day SMA	$5.14
200-Day SMA	$190.72
RSI (14)	51.23
Beta	1.53
52-Week High	$3,440.00
52-Week Low	$2.53

Volume Today	3.70K
Avg Daily Volume (30D)	7.89K
Relative Volume	0.47x
Volatility (10D)	121.78
Volatility (30D)	118.52
Free Float	77.06%

Analyst Consensus

N/A

Current Price $2.92

Mean Target N/A

52W Low$2.53 52W High$3,440.00

Current

Target

$2.53 $3,440.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG015879NG6

ISINUS20678X5023

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. It applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.